• Title of article

    Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

  • Author/Authors

    Agasthi, Pradyumna Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Narayanasamy, Hemalatha Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Sorajja, Dan Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Slack, James Department of Cardio-Oncology - Mayo Clinic, Arizona, USA , Mookadam, Farouk Department of Cardio-Oncology - Mayo Clinic, Arizona, USA

  • Pages
    5
  • From page
    1
  • To page
    5
  • Abstract
    Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejection fraction decline.
  • Keywords
    Decitabine Induced Delayed , Cardiomyopathy , Hematologic Malignancy
  • Journal title
    Case Reports in Cardiology
  • Serial Year
    2018
  • Record number

    2611118